VanEck Biotech ETF
BBH
BBH
112 hedge funds and large institutions have $180M invested in VanEck Biotech ETF in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 116 → 112 (-4)
36% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 36
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
112
Holding in Top 10
1
Calls
$375K
Puts
$203K
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.44M | |
| 3 | +$2.2M | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$1.74M |
| 5 |
JPMorgan Chase & Co
New York
|
+$874K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$597K | |
| 3 | -$505K | |
| 4 |
MML Investors Services
Springfield,
Massachusetts
|
-$445K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$414K |